Walgreens Boots Alliance Inc. (WBA) Receives $90.33 Consensus Target Price from Brokerages
Walgreens Boots Alliance Inc. (NASDAQ:WBA) has received a consensus rating of “Buy” from the eighteen analysts that are covering the firm. One investment analyst has rated the stock with a sell recommendation, four have issued a hold recommendation and thirteen have given a buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $90.33.
WBA has been the subject of a number of analyst reports. Robert W. Baird restated an “outperform” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Tuesday, October 4th. Wells Fargo & Co. initiated coverage on Walgreens Boots Alliance in a research report on Monday, October 31st. They issued an “outperform” rating for the company. Leerink Swann restated an “outperform” rating and issued a $95.00 price target on shares of Walgreens Boots Alliance in a research report on Monday, September 19th. Deutsche Bank AG restated a “buy” rating and issued a $94.00 price target on shares of Walgreens Boots Alliance in a research report on Wednesday, September 28th. Finally, Zacks Investment Research upgraded Walgreens Boots Alliance from a “hold” rating to a “buy” rating and set a $90.00 price target for the company in a research report on Monday, October 3rd.
In other Walgreens Boots Alliance news, EVP Kathleen Wilson-Thompson sold 23,996 shares of the firm’s stock in a transaction dated Thursday, September 8th. The stock was sold at an average price of $85.00, for a total value of $2,039,660.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director William C. Foote sold 2,067 shares of the firm’s stock in a transaction dated Wednesday, November 2nd. The stock was sold at an average price of $81.30, for a total value of $168,047.10. Following the completion of the sale, the director now directly owns 24,623 shares of the company’s stock, valued at approximately $2,001,849.90. The disclosure for this sale can be found here. 21.10% of the stock is owned by company insiders.
A number of large investors have recently modified their holdings of the company. Jolley Asset Management LLC increased its stake in Walgreens Boots Alliance by 104.5% in the second quarter. Jolley Asset Management LLC now owns 1,370 shares of the pharmacy operator’s stock worth $114,000 after buying an additional 700 shares during the period. Westbourne Investment Advisors Inc. purchased a new stake in Walgreens Boots Alliance during the second quarter worth approximately $121,000. Hudock Capital Group LLC increased its stake in Walgreens Boots Alliance by 0.4% in the third quarter. Hudock Capital Group LLC now owns 1,641 shares of the pharmacy operator’s stock worth $132,000 after buying an additional 7 shares during the period. Parasol Investment Management LLC increased its stake in Walgreens Boots Alliance by 3.5% in the third quarter. Parasol Investment Management LLC now owns 1,787 shares of the pharmacy operator’s stock worth $144,000 after buying an additional 60 shares during the period. Finally, Cribstone Capital Management LLC purchased a new stake in Walgreens Boots Alliance during the second quarter worth approximately $149,000. 60.36% of the stock is owned by institutional investors and hedge funds.
Shares of Walgreens Boots Alliance (NASDAQ:WBA) opened at 83.27 on Wednesday. The company has a market cap of $90.20 billion, a PE ratio of 21.80 and a beta of 1.19. Walgreens Boots Alliance has a one year low of $71.50 and a one year high of $87.05. The stock’s 50 day moving average is $80.84 and its 200-day moving average is $80.96.
Walgreens Boots Alliance (NASDAQ:WBA) last posted its earnings results on Thursday, October 20th. The pharmacy operator reported $1.07 EPS for the quarter, beating analysts’ consensus estimates of $0.99 by $0.08. The firm earned $28.60 billion during the quarter, compared to the consensus estimate of $29.06 billion. Walgreens Boots Alliance had a return on equity of 16.33% and a net margin of 3.56%. The company’s quarterly revenue was up .4% compared to the same quarter last year. During the same period in the prior year, the company earned $0.88 EPS. Equities research analysts expect that Walgreens Boots Alliance will post $5.01 earnings per share for the current year.
The firm also recently declared a quarterly dividend, which will be paid on Monday, December 12th. Shareholders of record on Thursday, November 17th will be issued a $0.375 dividend. This represents a $1.50 annualized dividend and a yield of 1.80%. The ex-dividend date is Tuesday, November 15th. Walgreens Boots Alliance’s dividend payout ratio is presently 39.27%.
Walgreens Boots Alliance Company Profile
Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).
Receive News & Stock Ratings for Walgreens Boots Alliance Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc. and related stocks with our FREE daily email newsletter.